Company page
Medy-tox Inc.
Medy-tox Inc. is a public company listed under the ticker 086900 on the Korean market. The company has a market capitalization of approximately 371.4 million USD. Medy-tox focuses on biopharmaceuticals and is involved in the development and production of botulinum toxin products.
- Ticker
- 086900:KRX
- Asset type
- Stock
- Market cap
- $371.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW